fetch image

Filter Results

Biologics / Biosimilars

KRISHGEN is the leading provider of tools used by the biopharmaceutical industry. We provide assays and reagents used for drug development from upstream monitoring of glycosylation to downstream impurities and contamination assays to bioanalytical assays for protein characterization as per FDA/EMA. We also offer some of the world’s only kits for pharmacokinetic studies and for post marketing surveillance for immunogenicity testing.

Antibodies for your Bioassays - PK / Immunogenicity - Bridging | Ligand Binding | Neutralizing

KRISHGEN offers highly specific, high affinity anti-biotherapeutic antibodies to support preclinical research, clinical trials and patient monitoring for innovator and biosimilar products from leading companies Bio-Rad, Sino Biologicals and Krishgen. Biorad uses the HuCAL recombinant monoclonal antibody library and an improved method of antibody phage display to generate these fully human antibodies in Fab and full immunoglobulin formats

Sino offers quality antibodies for developing your assays maintaining quality and consistency. Leading biosimilar companies in India procure these antibodies from us for their biosimilar assays. We are uniquely placed that when we sell these antibodies, we are also major users of these antibodies as we use them to develop our own assays which are commercially offered as ready-to-use ELISA kits.

Anti-idiotypic antibodies are able to recognize and bind to the idiotype of another antibody. KRISHGEN has various solutions to problems that you may encounter during the development of anti-idiotype antibodies and its assays for biocharacterization.

Anti-idiotype antibodies are widely used in therapeutic drugs studies:
  • Antibody drug immunogenicity studies
  • Vaccine development
  • Anti-drug antibodies (ADA) for clinical development
  • Antibody drug pharmacokinetic/pharmacodynamics (PK/PD) studies: detecting free, total or bound drug in blood

Bio-Rad is one of the world’s largest antibody producer supplying thousands of catalog antibodies and proteins. They include isotype specific secondary antibodies, phosphor-specific Precision antibodies, fluorescent western blotting antibodies and others including idiotypic antibodies for biopharma assays.

Due to its expertise in offering cataloged assays for pharmacokinetic, immunogenicity and neutralizing, we are able to offer well characeterized antibodies for your assays.

  • Krishzyme™ PNGase-F (glycerol-free), recombinant
  • Krishzyme™ PNGase-F, recombinant
  • Krishzyme™ Swift™ PNGase-F, recombinant
  • Krishzyme™ O-Glycosidase
  • Krishzyme™ α2-3,6,8,9 Neuraminidase
  • Krishzyme™ β 1-4 Galactosidase
  • Krishzyme™ β-N-Acetylhexosaminidase
  • Krishzyme™ Protein Deglycoslyation
  • Krishzyme™ Protein Deglycoslyation-NO Kit
  • Krishzyme™ Protein Deglycoslyation-NO2 Kit

  • 2AB Labelling Dye
  • Krishzyme™ DMB Sialic Acid Labelling Kit
  • Krishzyme™ S Clean Cartridge

  • Krishzyme Glyco NO Column 4.6mm x 150 mm
  • Krishzyme Glyco SC Column 7.5mm x 75 mm

    Quantitative Glycopeptide Standard
  • Asialo, agalacto, biantennary (NGA2)
  • Asialo, agalacto, triantennary N-Glycan (NGA3)
  • Asialo, agalacto,biantennary fucosylated (NGA2F)
  • Monogalactosylated asialo, biantennary (G-NGA2)
  • Asialo, galactosylated, biantennary (NA2)
  • Asialo, agalacto, tetraantennary (NGA4)
  • Asialo, agalacto, bisected triantennary (NGA3B)
  • Asialo, galactosylated, fucosylated, biantennary (G1F)
  • Asialo galactosylated, fucosylated, biantennary (NA2F)
  • Asialo, galactosylated, triantennary (NA3)
  • Asialo, galactosylated, fucosylated, bisected, biantennary (NA2FB)
  • Asialo, galactosylated, tetraantennary, N-linked Glycan (NA4)
  • Man-1-Fuc
  • Man-2(a)
  • Man-2(b)
  • Man-3(a)
  • Man-3(b)
  • Man-4(b)
  • Man-3-F
  • Man-5
  • Man-6
  • Man-7D1
  • Man-7D3
  • Man-8D1D3
  • Man-9
  • Man-9-Glc
  • A2 Glycan
  • A1F Glycan
  • A2F Glycan
  • A3 Glycan
  • 2AB-Labelled Glycans
  • NA4 Glycan, 2-AB labelled
  • NGA4 Glycan, 2-AB labelled
  • A3 Glycan, 2-AB labelled
  • NA3 Glycan, 2-AB labelled
  • NGA3 Glycan, 2-AB labelled
  • NA2F Glycan, 2-AB labelled
  • A2F Glycan, 2-AB labelled
  • A1F Glycan, 2-AB labelled
  • NGA2F Glycan, 2-AB labelled
  • G1F Glycan, 2-AB labelled
  • FA2B Glycan, 2-AB labelled
  • FA2BG1 Glycan, 2-AB labelled
  • A2 Glycan, 2-AB labelled
  • NA2 Glycan, 2-AB labelled
  • NGA2 Glycan, 2-AB labelled
  • M3N2 (Man-3) Glycan, 2-AB labelled
  • A2G1 Glycan, 2-AB labelled
  • Man-9 Glycan, 2-AB labelled
  • Man-8 Glycan, 2-AB labelled
  • Man-7 Glycan, 2-AB labelled
  • Man-6 Glycan, 2-AB labelled
  • Man-5 Glycan, 2-AB labelled
  • 2AA-Labelled Glycans
  • NA4 Glycan, 2-AA labelled
  • NGA4 Glycan, 2-AA labelled
  • A3 Glycan, 2-AA labelled
  • NA3 Glycan, 2-AA labelled
  • NGA3 Glycan, 2-AA labelled
  • A2F Glycan, 2-AA labelled
  • A1F Glycan, 2-AA labelled
  • NA2F Glycan, 2-AA labelled
  • NGA2F Glycan, 2-AA labelled
  • G1F Glycan, 2-AA labelled
  • FA2B Glycan, 2-AA labelled
  • FA2BG1 Glycan, 2-AA labelled
  • A2 Glycan, 2-AA labelled
  • NA2 Glycan, 2-AA labelled
  • NGA2 Glycan, 2-AA labelled
  • A2G1 Glycan, 2-AA labelled
  • M3N2 (Man-3) Glycan, 2-AA labelled
  • Man-9 Glycan, 2-AA labelled
  • Man-8 Glycan, 2-AA labelled
  • Man-7 Glycan, 2-AA labelled
  • Man-6 Glycan, 2-AA labelled
  • Man-5 Glycan, 2-AA labelled

KRIBIOLISA™ C1Q Protein

  • KRIBIOLISA™ C1Q Protein
  • KRIBIOLISA™ Rituximab (RITUXAN) C1Q Binding ELISA
  • KRIBIOLISA™ Infliximab (REMICADE) C1Q Binding ELISA
  • KRIBIOLISA™ Alemtuzumab (LEMTRADA) C1Q Binding ELISA
  • KRIBIOLISA™ Etarnacept (ENBREL) C1Q Binding ELISA
  • KRIBIOLISA™ Ustekinumab (STELARA) C1Q Binding ELISA
  • KRIBIOLISA™ Adalimumab (Humira) C1Q Binding ELISA
  • KRIBIOLISA™ Bevacuzimab (AVASTIN) C1Q Binding ELISA
  • KRIBIOLISA™ Trastuzumab (HERCEPTIN) C1Q Binding ELISA
  • KRIBIOLISA™ Cetuximab (ERBITUX) C1Q Binding ELISA
  • KRIBIOLISA™ Golimumab (SIMPONI) C1Q Binding ELISA
  • KRIBIOLISA™ Natalizumab (TYSABRI) C1Q Binding ELISA
  • KRIBIOLISA™ Omalizumab (XOLAIR) C1Q Binding ELISA
  • KRIBIOLISA™ Tocilizumab (ACTEMRA) C1Q Binding ELISA
  • KRIBIOLISA™ Eculizumab (SOLIRIS) C1Q Binding ELISA
  • KRIBIOLISA™ Ipilimumab (YERVOY) C1Q Binding ELISA
  • KRIBIOLISA™ Denosumab (PROLIA) C1Q Binding ELISA

The efficacy of a therapeutic antibody is dependent on the Fab fragment and its binding activity to the target antigen, as well as the Fc fragment and its interaction with key Fc receptors. The binding affinity of the Fc fragment towards FcRn (FCGRT

  • KRIBIOLISA™ Anti-Rituximab (RITUXAN) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Infliximab (REMICADE) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Alemtuzumab (LEMTRADA) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Etarnacept (ENBREL) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Ustekinumab (STELARA) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Adalimumab Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Bevacuzimab (AVASTIN) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Trastuzumab (HERCEPTIN) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Cetuximab (ERBITUX) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Golimumab (SIMPONI) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Natalizumab (TYSABRI) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Omalizumab (XOLAIR) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Tocilizumab (ACTEMRA) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti Eculizumab (SOLIRIS) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Ipilimumab (YERVOY) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Denosumab (PROLIA) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Atezolizumab (TECENTRIQ) Neutralizing Antibody (CLBA) ELISA
  • KRIBIOLISA™ Anti-Daratumumab (DARZALEX) Neutralizing Antibody (CLBA) ELISA

  • Anti-CD20 Reference Standard
  • Anti-Her2 Reference Standard
  • Recombinant ErbB2 Positive Control
  • Anti-EGFR Reference Standard
  • Recombinant EGFR Positive Control (his tag)
  • Anti-VEGF-A Reference Standard
  • Recombinant VEGF Positive Control
  • Anti-PDL-1 Reference Standard

Recombinant FSH

  • Reporter Assay Cells
  • Recombinant FSH Reference Standard
Recombinant LH
  • Reporter Assay Cells
  • Recombinant LH Reference Standard
Recombinant TSH
  • Reporter Assay Cells
  • Recombinant TSH Reference Standard
Aflibercept
  • Assay Cells (screened for Proliferation Assay)
  • VEGF165 Reference Standard
Ranibizumab
  • Assay Cells (screened for Proliferation Assay)
  • VEGF165 Reference Standard
Bevacizumab
  • Assay Cells (screened for Proliferation Assay)
  • VEGF165 Reference Standard
Pertuzumab
  • Assay Cells (screened for Proliferation Assay)
  • VEGF165 Reference Standard
Exenatide
  • GLP-1R Assay Cells
  • Anti-GLP1R Reference Standard
  • Exenatide Positive Control
Liraglutide
  • GLP-1R Assay Cells
  • Anti-GLP1R Reference Standard
  • Liraglutide Positive Control
Semaglutide
  • GLP-1R Assay Cells
  • Anti-GLP1R Reference Standard
  • Semaglutide Positive Control
Albiglutide
  • GLP-1R Assay Cells
  • Anti-GLP1R Reference Standard
  • Albiglutide Positive Control
Dulaglutide
  • GLP-1R Assay Cells
  • Anti-GLP1R Reference Standard
  • Dulaglutide Positive Control

● Rituximab ADCC Assay

  • Rituximab ADCC Assay Target Cells (Raji)
  • ADCC Assay Effector Cells
● Rituximab ADCC Assay (validated assay)
  • Rituximab ADCC Assay Target Cells (WIL2-S)
  • ADCC Assay Effector Cells
● Trastuzumab ADCC Assay (validated assay)
  • Trastuzumab ADCC Assay Target Cells (BT-474)
  • ADCC Assay Effector Cells
● Cetuximab ADCC Assay (validated assay)
  • Cetuximab ADCC Assay Target Cells (A431)
  • ADCC Assay Effector Cells
● Bevacizumab ADCC Assay
  • Bevacizumab ADCC Assay Target Cells (HUVECs)
  • ADCC Assay Effector Cells
● Pertuzumab ADCC Assay
  • Pertuzumab ADCC Assay Target Cells (HUVECs)
  • ADCC Assay Effector Cells
● Atezolimumab ADCC Assay
  • Atezolimumab ADCC Assay Target Cells (PDL-1)
  • ADCC Assay Effector Cells

The classic assay format is based on PBMC-derived macrophages as effector cells. After extraction of fresh human PBMCs, monocytes will be isolated and differentiated in culture to macrophages. The workflow is much more sophisticated than ADCC and usually takes more than one-week period. Phagocytosis events will be analyzed using FACS screening, and a dose-dependent curve will be generated to assess the ADCP potency in detail. Of note, effector cells from distinct donors cannot be pooled due to MHC restrictions. Hence, samples from a battery of donors must be applied to reduce donor-specific variability.


However, this is resolved today with off-the-shelf macrophages now available with Certificate of Analysis standardizing their isolation in cryopreserved formats.

No tedious steps Easy-to-use Macrophages now available !!!

Primary ADCP assay can be a powerful tool for early phage confirmation of in-vivo ADCP liability, as well as for biocompatibility assessment of biosimilars and biobetters.


The challenge to offer macrophages or do the isolation in-house led to alternate methods including reporter-gene based assays which are expensive to perform and still do not reflect the true MOA (mechanism of action) as they use engineered cell lines.

Macrophage-based ADCP assay can reflect the ADCP MOA with improved specificity, sensitivity, accuracy; it can also be established in quality control, drug development settings. Our fast, accurate, reproducible and cost-effective platform can deliver compelling data regarding in vivo ADCP bioactivities as well as lot release and stability evaluation.


Macrophages

Human M1 Macrophages (GM-CSF), monocyte-derived Human M2 Macrophages (M-CSF), monocyte-derived Primary human macrophages are hard to isolate from tissue in sufficient amounts with a homogeneous phenotype, do not proliferate in culture, and are difficult to handle in vitro. Krishgen’s cryopreserved human monocyte-derived macrophages (hMDM) provide a convenient and easy-to-handle solution. The thawed cells plate into all tissue culture vessel formats and can be maintained as adherent, biologically functional cultures for several weeks. Cryopreserved human macrophages are produced from human monocytes in well-proven M1/M2- Macrophage Generation Media DXF and are available as non-activated, fully qualified M1- (GM-CSF) or M2- (M-CSF) polarized cells. Each cryo-vial contains more than 1.5 million or 5 million viable cells after thawing, respectively.

Advantages

  • Assay-ready: Fully functional, adherent M1/M2 macrophages
  • Save time and start your experiments immediately with a defined cell number
  • Wide range of donors available
  • Each lot is tested for: CD68 , CD80 (M1); CD68 , CD163 (M2)
Call us to learn more or email your queries at: sales@krishgen.com

Product Name

Pack Size

Human M1 Macrophages (GM-CSF), Monocyte-derived, single donor

1,5 Mio cryopreserved cells

Human M1 Macrophages (GM-CSF), Monocyte-derived, single donor

5 Mio cryopreserved cells

Human M2 Macrophages (M-CSF), Monocyte-derived, single donor

1,5 Mio cryopreserved cells

Human M2 Macrophages (M-CSF), Monocyte-derived, single donor

5 Mio cryopreserved cells

  • KRIBIOLISA™ Rituximab (RITUXAN) ELISA
  • KRIBIOLISA™ Infliximab (REMICADE) ELISA
  • KRIBIOLISA™ Alemtuzumab (LEMTRADA) ELISA
  • KRIBIOLISA™ Etarnacept (ENBREL) ELISA
  • KRIBIOLISA™ Ustekinumab (STELARA) ELISA
  • KRIBIO LISA™ Adalimumab ELISA
  • KRIBIOLISA™ Bevacuzimab (AVASTIN) ELISA
  • KRIBIOLISA™ Trastuzumab (HERCEPTIN) ELISA
  • KRIBIOLISA™ Humanized Anti-Her2/neu (Herceptin/Trastuzumab) ELISA
  • KRIBIOLISA™ Cetuximab (ERBITUX) ELISA
  • KRIBIOLISA™ Golimumab (SIMPONI) ELISA
  • KRIBIOLISA™ Natalizumab (TYSABRI) ELISA
  • KRIBIOLISA™ Omalizumab (XOLAIR) ELISA
  • KRIBIOLISA™ Tocilizumab (ACTEMRA) ELISA
  • KRIBIOLISA™ Eculizumab (SOLIRIS) ELISA
  • KRIBIOLISA™ Ipilimumab (YERVOY) ELISA
  • KRIBIOLISA™ Denosumab (PROLIA) ELISA
  • KRIBIOLISA™ Atezolizumab (TECENTRIQ) ELISA
  • KRIBIOLISA™ Daratumumab (DARZALEX) ELISA
  • KRIBIOLISA™ Ranibizumab (Lucentis) ELISA

  • KRIBIOLISA™ Anti-Rituximab (RITUXAN) ELISA
  • KRIBIOLISA™ Anti-Rituximab (RITUXAN) ELISA (for rat species)
  • KRIBIOLISA™ Anti-Infliximab (REMICADE) ELISA
  • KRIBIOLISA™ Anti-Alemtuzumab (LEMTRADA) ELISA
  • KRIBIOLISA™ Anti-Etarnacept (ENBREL) ELISA
  • KRIBIOLISA™ Anti-Ustekinumab (STELARA) ELISA
  • KRIBIOLISA™ Anti-Adalimumab ELISA
  • KRIBIOLISA™ Anti-Bevacuzimab (AVASTIN) ELISA
  • KRIBIOLISA™ Anti-Trastuzumab (HERCEPTIN) ELISA
  • KRIBIOLISA™ Anti-Cetuximab (ERBITUX) ELISA
  • KRIBIOLISA™ Anti-Golimumab (SIMPONI) ELISA
  • KRIBIOLISA™ Anti-Natalizumab (TYSABRI) ELISA
  • KRIBIOLISA™ Anti-Omalizumab (XOLAIR) ELISA
  • KRIBIOLISA™ Anti-Tocilizumab (ACTEMRA) ELISA
  • KRIBIOLISA™ Anti Eculizumab (SOLIRIS) ELISA
  • KRIBIOLISA™ Anti-Ipilimumab (YERVOY) ELISA
  • KRIBIOLISA™ Anti-Denosumab (PROLIA) ELISA
  • KRIBIOLISA™ Anti-Atezolizumab (TECENTRIQ) ELISA
  • KRIBIOLISA™ Anti-Daratumumab (DARZALEX) ELISA
  • KRIBIOLISA™ Anti-Ranibizumab (Lucentis) ELISA
  • KRIBIOLISA™ Rat Anti-Ranibizumab (Lucentis) ELISA
  • KRIBIOLISA™ Anti-EPO (Erythropoetin) ELISA
  • KRIBIOLISA™ Antibodies to (S.Typhi) Typhoid Vi IgM ELISA
  • KRIBIOLISA™ Anti-AAV5 ELISA
  • KRIBIOLISA™ Anti-Human PTH (1-34) Antibody ELISA
  • KRIBIOLISA™ Anti-Glargine (LANTUS) ELISA
  • KRIBIOLISA™ Anti-Glargine (LANTUS) Development ELISA
  • KRIBIOLISA™ Anti-Asparte (NOVOLOG) ELISA

  • KRIBIOLISA™ Streptomycin ELISA
  • KRIBIOLISA™ Ampicillin ELISA
  • KRIBIOLISA™ Erythromycin ELISA
  • KRIBIOLISA™ Kanamycin ELISA
  • KRIBIOLISA™ Penicillin ELISA
  • KRIBIOLISA™ Tetracycline ELISA
  • KRIBIOLISA™ Tylosin ELISA
  • KRIBIOLISA™ Colimycin ELISA
  • KRIBIOLISA™ Gentamicin ELISA
  • KRIBIOLISA™ Neomycin ELISA

    KRIBIOLISA™ E.coli HCP ELISA
  • KRIBIOLISA™ Pichia Pastoris HCP ELISA
  • KRIBIOLISA™ CHO HCP ELISA
  • KRIBIOLISA™ SP 2/0 HCP ELISA
  • KRIBIOLISA™ Ovalbumin ELISA
  • KRIBIOLISA™ Human Serum Albumin ELISA
  • KRIBIOLISA™ Human IgG ELISA
  • KRIBIOLISA™ Human IgA ELISA
  • KRIBIOLISA™ Bovine Serum Albumin ELISA*
  • KRIBIOLISA™ Protein A ELISA
  • KRIBIOLISA™ Protein A ELISA (natural

  • KRIBIOLISA™ Insulin Glargine ELISA
  • KRIBIOLISA™ Insulin Aspart ELISA
  • KRIBIOLISA™ Angiotensin II ELISA
  • KRIBIOLISA™ BNP 32 (Human) (Natrecor) ELISA
  • KRIBIOLISA™ Buserelin (Suprefact)
  • KRIBIOLISA™ Calcitonin (Salmon) (Miacalcic) ELISA
  • KRIBIOLISA™ Chrysalin (PT508) ELISA
  • KRIBIOLISA™ D-Arg8-vasopressin ELISA
  • KRIBIOLISA™ Davalintide ELISA
  • KRIBIOLISA™ Degarelix (Firmagon) ELISA
  • KRIBIOLISA™ Deslorelin (Ovuplant) ELISA
  • KRIBIOLISA™ Desmopressin (Minirin) ELISA
  • KRIBIOLISA™ Dirucotide (MBP8298) ELISA
  • KRIBIOLISA™ Enfuvirtide (Fuzeon) ELISA
  • KRIBIOLISA™ Exenatide (Byetta) ELISA
  • KRIBIOLISA™ Fertirelin ELISA
  • KRIBIOLISA™ Glucagon (Glucagonito) ELISA
  • KRIBIOLISA™ Gonadorelin (LH-RH) (Factrel) ELISA
  • KRIBIOLISA™ Goserelin (Zoladex) ELISA
  • KRIBIOLISA™ Histrelin (Vantas) ELISA
  • KRIBIOLISA™ Leuprolide / Leuprorelin (Lupron) ELISA
  • KRIBIOLISA™ Liraglutide (Victoza) ELISA
  • KRIBIOLISA™ Lixisenatide ELISA
  • KRIBIOLISA™ Methionine-Enkephalin ELISA
  • KRIBIOLISA™ Nafarelin (Synarel) ELISA
  • KRIBIOLISA™ Octreotide (Sandostatin) ELISA
  • KRIBIOLISA™ Orexin A ELISA
  • KRIBIOLISA™ Oxyntomodulin (Glucagon 37) ELISA
  • KRIBIOLISA™ Secretin (Human) (Chirhotim) ELISA
  • KRIBIOLISA™ Secretin (Porcine) (Secretin) ELISA
  • KRIBIOLISA™ Semaglutide ELISA
  • KRIBIOLISA™ Somatostatin (Stilamin) ELISA
  • KRIBIOLISA™ Teriparatide (PTH -34) ELISA
  • KRIBIOLISA™ Triptorelin (Trelstar) ELISA
  • KRIBIOLISA™ VIP (H,B,P,R) (Aviptadil) ELISA
  • KRIBIOLISA™ Trastuzumab Emtansine ELISA
  • KRIBIOLISA™ Intact Brentuximab Vedotin ELISA
  • KRIBIOLISA™ EPO (Erythropoietin) ELISA
  • KRIBIOLISA™ Anti G-CSF ELISA
  • KRIBIOLISA™ EPO Alpha (Erythropoietin alpha) ELISA
  • KRIBIOLISA™ LH (Lutenizing Hormone) Bioassay ELISA
  • KRIBIOLISA™ FSH (Follicle Stimulating Hormone) Bioassay ELISA
  • KRIBIOLISA™ hCG (human Chorionic Gonadotropin) Bioassay ELISA
  • KRIBIOLISA™ PEG-GCSF (Pegylated Filgrastim) ELISA
  • KRIBIOLISA™ PEG ELISA
  • FastNuclease™ Endonuclease Serratia Marcescens ELISA
  • FastNuclease™ DNase-1 ELISA
  • KRIBIOLISA™ PD-1 ELISA
  • KRIBIOLISA™ PD-L1 ELISA

Enquire

Testimonials

Are You a Supplier ?

Join Krishgen as a verified supplier to connect with quality buyers, quote for real inquiries, and get more orders!

Our Premium Suppliers

Krishgen Support